DE3785602D1 - Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. - Google Patents
Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.Info
- Publication number
- DE3785602D1 DE3785602D1 DE8787103714T DE3785602T DE3785602D1 DE 3785602 D1 DE3785602 D1 DE 3785602D1 DE 8787103714 T DE8787103714 T DE 8787103714T DE 3785602 T DE3785602 T DE 3785602T DE 3785602 D1 DE3785602 D1 DE 3785602D1
- Authority
- DE
- Germany
- Prior art keywords
- prostaglandines
- glaucoma
- derivatives
- treatment
- eye hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000010412 Glaucoma Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83905686A | 1986-03-13 | 1986-03-13 | |
US89238786A | 1986-07-31 | 1986-07-31 | |
US07/022,046 US4883819A (en) | 1986-07-31 | 1987-03-05 | Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3785602D1 true DE3785602D1 (de) | 1993-06-03 |
DE3785602T2 DE3785602T2 (de) | 1993-09-02 |
Family
ID=27361778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787103714T Expired - Lifetime DE3785602T2 (de) | 1986-03-13 | 1987-03-13 | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0242580B1 (de) |
JP (1) | JPH0643313B2 (de) |
DE (1) | DE3785602T2 (de) |
ES (1) | ES2053458T3 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824857A (en) * | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
ES2042625T5 (es) * | 1987-04-03 | 2000-07-16 | Univ Columbia | Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular. |
US5212200A (en) * | 1987-09-18 | 1993-05-18 | R-Tech Ueno, Ltd. | Ocular hypotensive agents |
US5151444B1 (en) * | 1987-09-18 | 1999-07-06 | R Tech Ueno Ltd | Ocular hypotensive agents |
US6420422B1 (en) | 1987-09-18 | 2002-07-16 | Sucampo Pharmaceuticals, Inc. | Ocular hypotensive agents |
ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
US5166178B1 (en) * | 1987-09-18 | 1998-07-21 | R Tech Ueno Ltd | Ocular hypotensive agents |
US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US5321128A (en) * | 1988-09-06 | 1994-06-14 | Kabi Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
US6187813B1 (en) | 1990-04-10 | 2001-02-13 | Pharmacia & Upjohn Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
DE68929435T2 (de) * | 1988-09-06 | 2003-07-17 | Pharmacia Ab | Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension |
JP3164368B2 (ja) * | 1990-03-08 | 2001-05-08 | 塩野義製薬株式会社 | 15―デオキシプロスタグランジン誘導体 |
CA2042937C (en) * | 1990-05-22 | 2002-04-30 | Ryuji Ueno | Treatment of ocular hypertension with a synergistic combination |
EP0458589B1 (de) * | 1990-05-22 | 1995-01-18 | R-Tech Ueno Ltd. | Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination |
DE69105349T2 (de) * | 1990-05-22 | 1995-04-06 | Ueno Seiyaku Oyo Kenkyujo Kk | Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung. |
US5270049A (en) * | 1990-11-09 | 1993-12-14 | Allergan, Inc. | 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
TW210287B (de) * | 1991-03-01 | 1993-08-01 | Kabushikaisha Ueno Seiyaku Oyo Kenkyujo | |
US5468778A (en) * | 1992-09-24 | 1995-11-21 | Allergan, Inc. | Method of lowering intraocular pressure by administering a pharmaceutical composition containing 7-(5-substituted cyclopentyl) and 7-(5-substituted-cyclopentenyl) 5-heptenoic acids and derivatives |
US5385945A (en) * | 1992-10-21 | 1995-01-31 | Allergan, Inc. | 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
CA2138181A1 (en) * | 1993-12-15 | 1995-06-16 | Verney L. Sallee | Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
SE9403160D0 (sv) * | 1994-09-21 | 1994-09-21 | Pharmacia Ab | Method and means for prevention and treatment of secondary cataract |
SE9403158D0 (sv) * | 1994-09-21 | 1994-09-21 | Pharmacia Ab | New use of prostaglandins |
SE9900672D0 (sv) * | 1999-02-25 | 1999-02-25 | Synphora Ab | Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3986764A (en) * | 1975-03-31 | 1976-10-19 | Gte Automatic Electric Laboratories Incorporated | Panel for supporting a pair of elongated mating connectors and selectively locking them together |
US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
-
1987
- 1987-03-13 ES ES87103714T patent/ES2053458T3/es not_active Expired - Lifetime
- 1987-03-13 EP EP87103714A patent/EP0242580B1/de not_active Expired - Lifetime
- 1987-03-13 JP JP62058688A patent/JPH0643313B2/ja not_active Expired - Lifetime
- 1987-03-13 DE DE8787103714T patent/DE3785602T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0242580A3 (en) | 1990-05-02 |
EP0242580A2 (de) | 1987-10-28 |
DE3785602T2 (de) | 1993-09-02 |
JPS6366122A (ja) | 1988-03-24 |
EP0242580B1 (de) | 1993-04-28 |
ES2053458T3 (es) | 1994-08-01 |
JPH0643313B2 (ja) | 1994-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3785602D1 (de) | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. | |
DE3788984D1 (de) | Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom. | |
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE69019774D1 (de) | Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie. | |
ATE131068T1 (de) | Behandlung von pathologischen zuständen und krankheiten. | |
NO862528D0 (no) | Metode for aa forhindre ocular hypertensjon, behandling av glaucoma og behandling av ocular hypertensjon. | |
ATE31670T1 (de) | Verfahren zur behandlung von verpackungsmaterial und das dementsprechend behandelte material. | |
DE3683318D1 (de) | Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege. | |
DE3587741D1 (de) | Behandlung von Hautkrankheiten. | |
DE3788057D1 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
KR900701323A (ko) | 신규한 녹내장 치료용 안과 제제 | |
DE3782028D1 (de) | Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen. | |
DE68923219D1 (de) | Behandlung von Abfällen. | |
ATE100826T1 (de) | Behandlung von celluloseblaettern. | |
DE3673913D1 (de) | Ophthalmische gelzubereitung und verfahren zur behandlung von augeninfektionen. | |
DE68903208D1 (de) | Verfahren zur thermischen behandlung von laktoferrin. | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
DE69004301D1 (de) | Mischung zur Behandlung der von exokrinen Insuffizienz der Bauchspeicheldrüse und die Verwendung der genannten Mischung. | |
DE3586420D1 (de) | Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose. | |
NO920983L (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
ATE88636T1 (de) | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augenhypertension und glaukom. | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
ATE136463T1 (de) | Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen | |
DE3668338D1 (de) | Kontinuierliche behandlung von spannungslosem gewebe. | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Free format text: DERZEIT KEIN VERTRETER BESTELLT |